131I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma

被引：2
|
作者：
Castro, Gabriel [1 ]
Berrocal, Isabel [1 ]
Carmona, Jaime [1 ]
Gonzalez, Javiera [1 ]
Gonzalez, Patricio [1 ]
机构：
[1] Univ Chile, Clin Hosp, Nucl Med Sect, Independencia, Santiago De Chi, Chile
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷 / 08期
关键词：
Omeprazole; Differentiate Thyroid Cancer; Differentiate Thyroid Carcinoma; Radioiodine Therapy; Visual Score;
D O I：
10.1007/s00259-012-2104-1
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1356 / 1357
页数：2
相关论文
共 50 条
  • [1] 131I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma
    Gabriel Castro
    Isabel Berrocal
    Jaime Carmona
    Javiera González
    Patricio González
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 1356 - 1357
  • [2] Radioiodine (131I) uptake in distant Metastases as a predicting factor of survival in differentiated thyroid carcinoma patients
    Mihailovic, J.
    Stefanovic, L.
    Malesevic, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S231 - S231
  • [3] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Gerali, S
    Koutsikos, J
    Tsiouris, S
    Mainta, E
    Lucchetti, S
    Papathanasiou, G
    Fotinaki, E
    Makripoulias, V
    Kotsias, D
    Palestidis, C
    Zerva, C
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S425 - S425
  • [4] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Zerva, C.
    Koutsikos, J.
    Palestidis, C.
    Kounadi, E.
    Gerali, S.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (04): : 348 - 354
  • [5] The Diagnostic Contribution and Clinical Impact of 131I SPECT/CT in the Evaluation of Extrathyroidal Uptake in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy
    Bahceci, T.
    Ozdemir, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S702 - S702
  • [6] Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma
    Verburg, Frederik A.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 253 - 257
  • [7] Analysis of the 131I therapy in the young and adolescent patients with differentiated thyroid carcinoma
    Wang, Jiantao
    Kuang, Anren
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [8] Implications of mediastinal uptake of 131I with regard to surgery in patients with differentiated thyroid carcinoma
    Haveman, JW
    Phan, HTT
    Links, TP
    Jager, PL
    Plukker, JTM
    [J]. CANCER, 2005, 103 (01) : 59 - 67
  • [9] Diagnostic 121I and 131I activities and radioiodine therapy -: Effects on urinary iodine excretion in patients with differentiated thyroid carcinoma
    Meller, B
    von Hof, K
    Genina, E
    Deisting, W
    Meller, J
    Richter, E
    Baehre, M
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2005, 44 (06): : 243 - 248
  • [10] The efficiency of planning of therapeutic 131I activities in the radioiodine therapy of differentiated thyroid cancer
    Sinyuta, B
    Dzhuzha, D
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1004 - 1004
12345